Publication Topic

Jensen I, Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543.

Meddings J, Reichert H, Smith S, Iwashyna T, Langa K, Hofer T, McGuirk H, McMahon LF Jr. Functional status, social support and wealth impact readmissions for pneumonia and heart failure beyond standard Medicare risk-adjustors. Academy Health Annual Research Meeting, June 14-15, 2015, Minneapolis, MN.

Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Comparison of trends in bronchiolitis and respiratory syncytial virus infant hospitalizations rates in 3 US nationally representative databases. Presented at the Pediatric Academic Societies Annual Meeting, San Diego, CA, April 2015.

Babik I, Libassi L, Movva N, Lobo MA. Rehabilitation intervention changing the dynamics of movement in children with arthrogryposis. Poster presentation at the Society for Research in Child Development Biennial Conference, Philadelphia, PA, March 2015.

Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL, Jensen IS. A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10, ISPOR 17th Annual European Congress 2014.

Greene T, Kiyoshi-Teo H, Reichert H, Krein S, Saint S. 2014. Urinary catheter indications in the United States: Results from a national survey of acute care hospitals. Infect Contr Hosp Epidemiol 35(Sup 3):S96-S98; doi: 10.1086/677823. PMID: 25222904.

Movva N, Babik I, Galloway JC, Lobo MA. Use of an innovative rehabilitation device for infants to improve upper extremity functionality. Poster presentation at the Undergraduate Research and Service Celebratory Symposium, Newark, DE, August 2014.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: How do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.

Reichert H, McMahon LF, Meddings J. Did hospital-acquired pressure ulcer rates decrease after implementation of non-payment as a comorbidity with the 2008 Hospital-Acquired Conditions Initiative? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.

Meddings J, Reichert H, Dueweke E, Rhyner J. 2014. Issues regarding identification of urinary catheter use from medical records. In: Battles JB, Cleeman JI, Kahn KK, Weinberg DA, eds. Advances in the Prevention and Control of Healthcare-Associated Infections. Rockville (MD): Agency for Healthcare Research and Quality (US).

Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14, Academy of Managed Care Pharmacy 26^th Annual Meeting & Expo, 2014.

Reichert H, McMahon LF, Meddings J. Hospital-acquired catheter-associated urinary tract infections: Reported by mandate to the National Healthcare Safety Network, but rarely listed as diagnoses in claims data. Presented at the Society of General Internal Medicine Annual Meeting, San Diego, CA, April 2014.

Jensen IS, Halbert RJ, Grosvenor A, Swartz E, Rossi G, Naoshy S, et al. Incorporating stakeholder input into budget impact models to compare stem cell mobilization strategies. Abstract PCN43, ISPOR 18th Annual International Meeting, 2013.

Meddings J, Reichert H, Hofer T, McMahon L. 2013. Hospital report cards for hospital-acquired pressure ulcers: How good are the grades? Ann Internal Med 159(8):505–513; doi: 10.7326/0003-4819-159-8-201310150-00003. PMID: 24126644.

Sacks NC, Burgess JF, Cabral HJ, Pizer SD, McDonnell, ME. 2013. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries. J Gen Intern Med 28(7):876–885; doi: 10.1007/s11606-013-2342-3. PMID: 23404199.